MBX Biosciences’ investigational drug MBX 2109 received Orphan Drug designation from the FDA for treatment of hypoparathyroidism.
The FDA has expanded its approval to Janssen’s Stelara (ustekinumab) for treatment of pediatric patients six years and older with psoriatic arthritis.
Imperial researchers contribute to a report highlighting how air pollution contributes to dementia and a decline in mental ability.
From today, determining the 3D shape of almost any protein known to science will be as simple as typing in a Google search.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.